
Sign up to save your podcasts
Or
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention.
Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577
4.8
129129 ratings
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention.
Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577
128 Listeners
280 Listeners
315 Listeners
34 Listeners
481 Listeners
13 Listeners
90 Listeners
21 Listeners
173 Listeners
341 Listeners
510 Listeners
320 Listeners
181 Listeners
362 Listeners
73 Listeners